drugset / Trial / NCT03645499

An Open-Label Study to Assess Safety

NCT03645499 ↗

Phase 1 Completed 88 enrolled Sun Pharmaceutical Industries, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

An Open-Label study to assess safety

Timeline

Start
2018-04-04
Primary completion
2019-10-24
Completion
2020-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Topical TA-102 A Unknown — Topical
Subject Topical TA-102 B Unknown — Topical
Subject Topical TA-102 C Unknown — Topical
Subject Topical TA-102 D Unknown — Topical
Subject Topical TA-102 E Unknown — Topical

Indications